Self-limited bursts of atrial fibrillation following successful cardioversion

International Journal of Cardiology

Volumn 119, Issue 1, 2007, Pages 95-100

  Nergårdh, Anna K ^a   Rosenqvist, Mårten ^a   Frick, Mats ^a  

^a STOCKHOLM SÖDER HOSPITAL   (Sweden)

Author keywords

Arrhythmia; Atrial fibrillation; Cardioversion

Indexed keywords

ARTICLE; CARDIOVERSION; ELECTROCARDIOGRAM; FOLLOW UP; HEART ATRIUM FIBRILLATION; HOLTER MONITORING; HUMAN; INCIDENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENCE RISK; SINUS RHYTHM;

AGED; ATRIAL FIBRILLATION; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RECURRENCE;

EID: 34249330893     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.08.007     Document Type: Article

References (22)

1. Kannel W.B., Abbott R.D., Savage D.D., and Mc Namara P.M. Epidemiological features of chronic atrial fibrillation: the Framingham study. N Engl J Med 306 (1982) 1018-1022
2. Kalman J.M., and Tonkin A.M. Atrial fibrillation: epidemiology and the risk and prevention of stroke. PACE Pacing Clin Electrophysiol 15 (1992) 1332-1346
3. Page R., Wilkinson W., Clair W., McCarthy E.A., and Pritchett E.L. Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation 89 (1994) 224-227
4. Savelieva I., and Camm A.J. Clinical relevance of silent atrial fibrillation: prevalence, prognosis, quality of life, and management. J Interv Cardiac Electrophysiol 4 (2000) 369-382
5. Wolf P.A., Kannel W.B., McGee D.L., Meeks S.L., Bharucha N.E., and McNamara P.M. Duration of atrial fibrillation and imminence of stroke: the Framingham Study. Stroke 14 (1983) 664-667
6. Lin H.J., Wolf P.A., Benjamin E.J., Belanger A.J., and D'Agostino R.B. Newly diagnosed atrial fibrillation and acute stroke: the Framingham Study. Stroke 26 (1995) 1527-1530
7. Wyse D.G., Waldo A.L., DiMarco J.P., et al. Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347 (2002) 1825-1833
8. Van Gelder I.C., Hagens V.E., Bosker H.A., et al. Rate control versus electrical cardioversion for persistent atrial fibrillation study group. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 347 (2002) 1834-1840
9. Wolk R., Kulakowski P., Karczmarewicz S., et al. The incidence of asymptomatic paroxysmal atrial fibrillation in patients treated with propanolol or propafenone. Int J Cardiol 54 (1996) 207-211
10. Reimold S.C., Cantillon C.O., Friedman P.L., and Antman E.M. Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation. Am J Cardiol 71 (1993) 558-563
11. Juul-Möller S., Edvardsson N., and Rehnqvist-Ahlberg N. Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation. Circulation 82 (1990) 1932-1939
12. Frick M., Darpö B., Östergren J., and Rosenqvist M. The effect of oral magnesium, alone or as an adjuvant to sotalol, after cardioversion in patients with persistent atrial fibrillation. Eur Heart J 21 14 (2000) 1177-1185
13. Bhandari A., Anderson J., Gilbert M., et al. Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation: A transtelephonic monitoring study. Am Heart J 124 (1992) 381
14. Clair W., Wilkinson W., McCarhty E., Page R.L., and Pritchett E. Spontaneous occurrence of symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia in untreated patients. Circulation 87 (1993) 1114-1122
15. Wolpert C., Jung W., Spehl S., et al. Incidence and rate characteristics of atrial tachyarrhythmias in patients with a dual chamber defibrillator. PACE Pacing Clin Electrophysiol 26 (2003) 1691-1698
16. Page R.L., Tilsch T.W., Connolly S.J., et al. Azimilide Supraventricular Arrhythmia Program (ASAP) Investigators. Asymptomatic or "silent" atrial fibrillation; frequency in untreated patients and patients receiving azimilide. Circulation 107 (2003) 1141-1145
17. Li-Saw-Hee F.L., Blann A.D., and Lip G.Y. A cross-sectional and diurnal study of thrombogenesis among patients with chronic atrial fibrillation. J Am Coll Cardiol 35 (2000) 1926-1931
18. Sohara H., Amitani S., Kurose M., and Miyahara K. Atrial fibrillation activates platelets and coagulation in a time-dependent manner: a study in patients with paroxysmal atrial fibrillation. J Am Coll Cardiol 29 (1997) 106-112
19. Gustafsson C., Blomback M., Britton M., Hamsten A., and Svensson J. Coagulation factors and the increased risk of stroke in nonvalvular atrial fibrillation. Stroke 21 (1990) 47-51
20. Ribera J.M., Cruz A.J., Zamorano J.L., and Perez-Casar F. Cardiac rate and hyperkinetic rhythm disorders in healthy elderly subjects: evaluation by ambulatory electrocardiographic monitoring. Gerontology 35 2-3 (1989) 158-164
21. Wajngarten M., Grupi C., Bellotti G.M., Da Luz P.L., Azul L.G., and Pileggi F. Frequency and significance of cardiac rhythm disturbances in healthy elderly individuals. J Electrocardiol 23 2 (1990) 171-176
22. Kantelip J., Sage E., and Duchene Marullaz P. Findings on ambulatory electrocardiographic monitoring in subjects older than 80 years. Am J Cardiol 57 (1986) 398-401